SDHB mutations are strongly associated with extra-adrenal sympathetic paragangliomas with an increased risk of metastatic disease, and less frequently, with Pheos and parasympathetic PGLs (Andrews et al., 2018). Here, SDHB is linked to sympathetic paraganglioma.